Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 15
Original Research
Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,208 | Dovepress* | 4,611+ | 128 | 4,739 | |
| PubMed Central* | 597 | 349 | 946 | ||
| Totals | 5,208 | 477 | 5,685 | ||
| *Since 20 October 2022 | |||||
View citations on PubMed Central and Google Scholar